Inovio Pharmaceuticals and Kaneka Eurogentec, a unit of Kaneka, a Japanese chemical company, have entered a manufacturing agreement to produce Inovio's COVID-19 vaccine candidate, although no details were disclosed regarding the deal's terms. Another manufacturing deal has also been made by Inovio with Thermo Fisher to boost its vaccine supply.
Inovio, Kaneka partner for COVID-19 vaccine production
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.